Search
for
Sort by
Research 61–90 of 289
- The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
- The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- Anticoronavirus Isoquinoline Alkaloids: Unraveling the Secrets of Their Structure–Activity Relationship
- Gender Differences in Response to COVID-19 Infection and Vaccination
- Perspective Chapter: Repurposing Natural Products to Target COVID-19 – Molecular Targets and New Avenues for Drug Discovery
- Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
- A review on computer‐aided chemogenomics and drug repositioning for rationalCOVID‐19 drug discovery
- Matriptase Expression and Zymogen Activation in Human Pilosebaceous Unit
- Evolution, classification, structure, and functional diversification of steroid 5α-reductase family in eukaryotes
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- mRNA Levels of Aromatase, 5α-Reductase Isozymes, and Prostate Cancer-Related Genes in Plucked Hair from Young Men with Androgenic Alopecia
- The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Late unexpected consequences of COVID‐19 infection in survivors of acute hypoxic respiratory failure
- Comment on “Androgens and women: COVID‐19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism”
- COVID‐19, androgens, and androgenic alopecia
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- COVID-19 and Sex Differences
- Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
- Correlation Between Nongenomic Action of C19-Steroids and COVID-19 Severity
- Androgen deprivation therapy and hormonal status in men with COVID-19
- Recommendations on trichological treatments during COVID-19 pandemic
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- The Transmembrane Serine Protease HAT-like 4 Is Important for Epidermal Barrier Function to Prevent Body Fluid Loss
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Clinical symptoms of hyperandrogenic women diagnosed with COVID‐19
- Expression of concern: potential risk for developing severe COVID-19 disease among anabolic steroid users
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review